£166.46

Springer Clinical Use of Antiviral Drugs: 3 (Developments in Medical Virology, 3)

Price data last checked 57 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£166 today · previous high £166 · all-time low £165

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 34 days • 34 data points (No recent data available)

Historical
Generating forecast...
£166.46 £164.48 £164.91 £165.34 £165.78 £166.21 £166.64 23 March 2026 31 March 2026 08 April 2026 16 April 2026 25 April 2026

Price Distribution

Price distribution over 34 days • 2 price levels

Days at Price
Current Price
26 days 8 days · current 0 7 13 20 26 £165 £166 Days at Price

Price Analysis

Most common price: £165 (26 days, 76.5%)

Price range: £165 - £166

Price levels: 2 different prices over 34 days

Description

Antiviral chemotherapy has come of age, and, after an initial slow pro gress, the development of new antiviral agents has proceeded at a more rapid pace and the perspectives for their clinical use have increased considerably. Now, 25 years after the first antiviral assay (idoxuridine) was introduced in the clinic, it is fitting to commemorate the beginning of the antivirals' era. In its introductory chapter B.E. Juel-Jensen touches on what may be con sidered as five of the most fundamental requirements of an antiviral drug : efficacy, relative non-toxicity, easy solubility, ready availability and rea sonable cost. Surely, the antiviral drugs that have so far been used in the clinic could still be improved upon as one or more of these five essential demands are concerned. How is all began is narrated by W.H. Prusoff. The first antiviral drugs to be used in humans were methisazone and idoxuridine, the former, which is now of archival interest, in the prevention of smallpox, the latter, which was approved for clinical use in the United States in 1962, for the topical treatment of herpetic keratitis. In terms of potency, also because of solubility reasons, idoxuridine has been superseded by trifluridine in the topical treatment of herpes simplex epithelial keratitis. H.E. Kaufman did not find trifluridine or acyclovir ef fective in the treatment of deep stromal keratitis or iritis and he reckons that other antiviral drugs (i.e. bromovinyldeoxyuridine) would not be effec tive either.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Clinical Use of Antiviral Drugs: 3 (Developments in Medical Virology, 3)
99% match

Clinical Use of Antiviral Drugs: 3 (Developments in Medical Virology, 3)

Springer

£146.58 20 Jun 2026
Color Atlas of Herpetic Eye Disease: A Practical Guide to Clinical Management
94% match

Color Atlas of Herpetic Eye Disease: A Practical Guide to Clinical Management

Springer

£123.95 20 Jun 2026
Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)
94% match

Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)

Springer

£149.64 02 Apr 2026
Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)
94% match

Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)

Springer

£152.38 08 Mar 2026
Biopharmaceutics and Drug Hypersensitivity (Pharmacology - Research, Safety Testing and Regulation)
94% match

Biopharmaceutics and Drug Hypersensitivity (Pharmacology - Research, Safety Testing and Regulation)

£142.83 11 Mar 2026
Chemotherapy of Viral Infections: 61 (Handbook of Experimental Pharmacology)
94% match

Chemotherapy of Viral Infections: 61 (Handbook of Experimental Pharmacology)

Springer

£96.07 11 Apr 2026
Springer - Uveitis and Immunological Disorders Book
94% match

Springer - Uveitis and Immunological Disorders Book

Springer

£78.37 01 May 2026
Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: 394 (Advances in Experimental Medicine and Biology)
93% match

Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: 394 (Advances in Experimental Medicine and Biology)

Springer

£146.81 20 Jun 2026
Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: 394 (Advances in Experimental Medicine and Biology, 394)
93% match

Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: 394 (Advances in Experimental Medicine and Biology, 394)

Springer

£107.42 17 Jun 2026
The Herpesviruses (The Viruses)
93% match

The Herpesviruses (The Viruses)

Springer

£78.01 27 Feb 2026
Extemporaneous Ophthalmic Preparations
93% match

Extemporaneous Ophthalmic Preparations

Springer

£42.92 17 May 2026
Immunobiology and Prophylaxis of Human Herpesvirus Infections: 278 (Advances in Experimental Medicine and Biology, 278)
93% match

Immunobiology and Prophylaxis of Human Herpesvirus Infections: 278 (Advances in Experimental Medicine and Biology, 278)

Springer

£77.71 13 Mar 2026
Antiviral Compounds From Plants
93% match

Antiviral Compounds From Plants

CRC Press

£93.25 09 May 2026
Current Topics in Microbiology and Immunology: 97
93% match

Current Topics in Microbiology and Immunology: 97

Springer

£89.99 07 Mar 2026
Ophthalmic Drug Therapy Pocket Guide, Clinical Ophthalmology
93% match

Ophthalmic Drug Therapy Pocket Guide, Clinical Ophthalmology

Xlibris Us

£113.99 09 Mar 2026
Ocular Infections (Essentials in Ophthalmology)
93% match

Ocular Infections (Essentials in Ophthalmology)

Springer

£86.95 01 Mar 2026
Herpetic Eye Diseases: Proceedings of the International Symposium at the Katholieke Universiteit Leuven, Leuven, Beglium, May 17–19, 1984: 44 (Documenta Ophthalmologica Proceedings Series, 44)
93% match

Herpetic Eye Diseases: Proceedings of the International Symposium at the Katholieke Universiteit Leuven, Leuven, Beglium, May 17–19, 1984: 44 (Documenta Ophthalmologica Proceedings Series, 44)

Springer

£72.00 17 Feb 2026
Principles of Virology, Volume 2: Pathogenesis and Control
93% match

Principles of Virology, Volume 2: Pathogenesis and Control

ASM Press

£73.75 16 Jun 2026
Vision Research Protocols: 47 (Methods in Molecular Medicine, 47)
93% match

Vision Research Protocols: 47 (Methods in Molecular Medicine, 47)

Humana

£83.91 12 Jun 2026
The Southern African Guide to Topical Ophthalmic Drugs
93% match

The Southern African Guide to Topical Ophthalmic Drugs

notionpress.com

£23.20 09 May 2026
A Practical Guide to Clinical Virology
93% match

A Practical Guide to Clinical Virology

Wiley

£106.00 11 Jun 2026
Principles of Virology, Volume 1: Molecular Biology
93% match

Principles of Virology, Volume 1: Molecular Biology

ASM Press

£72.59 14 Feb 2026
2021-2022 Basic and Clinical Science Course, Section 01: Update on General Medicine
93% match

2021-2022 Basic and Clinical Science Course, Section 01: Update on General Medicine

American Academy of Ophthalmology

£170.00 10 Feb 2026
Clinical and Diagnostic Virology
93% match

Clinical and Diagnostic Virology

Cambridge University Press

£51.95 17 Mar 2026